SmartPumps are tourniquet systems offering OR connectivity, superior performance, exceptional battery life and intuitive cuff controls.
They support today’s paper chart environment with an optional Tourniquet Report Printer that automatically documents intraoperative tourniquet data. This report is printed on a 2-by-3-inch self-adhesive label.
As the OR evolves, it can communicate with Clinical Information Systems (CIS) and is forward compatible with fully integrated operating rooms.

A retrospective study at Northwestern University Feinberg School of Medicine, Chicago, showed that dialysis patients who had implantable cardiac defibrillator (ICD) therapy were more likely to receive appropriate shocks for ventricular tachycardia or ventricular fibrillation — but they also had worse survival compared with a nondialysis cohort, according to Medscape Medical News.

Catheters of all types as well as other intravascular devices (IVDs) that allow access to the bloodstream are potential sources of infection, according to research at University of Wisconsin Hospital, Madison. HealthDay News reported on the study, which collected data from more than 200 studies and found that no one device was infection-proof.

A new study in Denmark links healthy teeth and gums with heart health.

Theheart.org reports that Danish investigators have observed an increased risk of coronary heart disease among adults with periodontal disease. In adults 60 years old or younger —with more than 4 mm of alveolar bone loss, as measured by clinical radiography —a significant sixfold increase in the risk of coronary heart disease was documented.

Public confidence in the FDA is low and big changes may be in order to fix the system for approving and regulating drugs, according to a new report by the Institute of Medicine (IOM).

Initiated by the agency itself, the report concludes that Congress, the FDA and the pharmaceutical industry share responsibility for the problems and should bare the burden for developing and implementing solutions.

A new, private research group, the Center for Medical Technology Policy is being formed to provide healthcare clinicians, payers and policymakers with evidence on the effectiveness and safety of emerging surgical procedures, medical devices, diagnostics and biopharmaceuticals, according to a ModernHealthcare.com report.

Americans Andrew Z. Fire and Craig C. Mello have won the Nobel Prize in medicine Monday for their discover of “RNA interference,” a powerful way to turn off the effect of specific genes.

A Yahoo!News story reports that the technique is already being widely used in basic science as a way to study the function of genes, and it is being studied as a treatment for infections such as the AIDS and hepatitis viruses, as well as other conditions, including heart disease and cancer.

Researchers at the Technion Institute, Israel, are developing a new method that may prevent heart attacks following angioplasty, Reuters reported.

Still several years from commercial availability, the technique clears clogged arteries by administering a pill containing a "prodrug” that is only activated when it comes in contact with a specific enzyme attached to the stent. A precise amount of the drug is delivered to exactly the point it is needed.

FDA and Duke Clinical Research Institute will be working to develop a new generation of tools that enable early identification of potential cardiac side effects of drugs and devices. The agency will use a database comprising more than 200,000 ECGs to conduct the research.

ATS Medical, Inc., a manufacturer of cardiac surgery products and services focused, has announced completion of its acquisition of 3F Therapeutics, a privately held company that develops and commercializes fundamentally unique tissue heart valve products.

"We believe we are now well positioned to enter the tissue heart valve market with products that are differentiated from those that are currently available and that will offer outstanding benefits to surgeons and their patients," said Michael Dale, chairman, president and CEO of ATS Medical.

Subscribe Now